Literature DB >> 16770648

Does obstructive sleep apnea increase hematocrit?

Jong Bae Choi1, José S Loredo, Daniel Norman, Paul J Mills, Sonia Ancoli-Israel, Michael G Ziegler, Joel E Dimsdale.   

Abstract

This study assessed the relationship between hematocrit levels and severity of obstructive sleep apnea (OSA) and examined how this relationship was affected by the degree of hypoxia as well as by possible confounding factors. Two-hundred sixty three subjects (189 men and 74 women) underwent nocturnal polysomnography with oximetry and had measurements of hematocrit, hemoglobin, white blood cell count, body mass index (BMI), blood pressure (BP), and 24-h urine norepinephrine (NE). Patients with severe OSA [respiratory disturbance index (RDI) >30] had significantly higher hematocrit values than patients with mild to moderate OSA or nonapneic controls (p < 0.01). However, only one patient had a hematocrit in the range of clinical polycythemia. Hematocrit levels were significantly correlated with BMI, BP, urinary NE, RDI, percent of time spent at oxygen saturation <90%, and with mean oxygen saturation. Multiple linear regression analysis revealed that mean oxygen saturation, RDI, and percent of time spent at oxygen saturation <90% were significant predictors of hematocrit level, even after controlling for gender, ethnicity, 24-h urine NE, BMI, and BP (p < 0.05). The severity of OSA is significantly associated with increased hematocrit, even after controlling for possible confounding variables. However, nocturnal hypoxemia in OSA does not usually lead to clinical polycythemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770648     DOI: 10.1007/s11325-006-0064-z

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  27 in total

Review 1.  Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force.

Authors: 
Journal:  Sleep       Date:  1999-08-01       Impact factor: 5.849

2.  Overnight decrease in hematocrit after nasal CPAP treatment in patients with OSA.

Authors:  J Krieger; E Sforza; M Barthelmebs; J L Imbs; D Kurtz
Journal:  Chest       Date:  1990-03       Impact factor: 9.410

3.  Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure.

Authors:  J Krieger; L Laks; I Wilcox; R R Grunstein; L J Costas; J G McDougall; C E Sullivan
Journal:  Clin Sci (Lond)       Date:  1989-10       Impact factor: 6.124

4.  Secondary polycythaemia associated with nocturnal apnoea--a relationship not mediated by erythropoietin?

Authors:  J T Carlson; J Hedner; B Fagerberg; H Ejnell; B Magnusson; F Fyhrquist
Journal:  J Intern Med       Date:  1992-04       Impact factor: 8.989

5.  Effect of standing on neurohumoral responses and plasma volume in healthy subjects.

Authors:  G Jacob; A C Ertl; J R Shannon; R Furlan; R M Robertson; D Robertson
Journal:  J Appl Physiol (1985)       Date:  1998-03

6.  Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk.

Authors:  Stephan Steiner; Thomas Jax; Stefanie Evers; Marcus Hennersdorf; Andreas Schwalen; Bodo E Strauer
Journal:  Cardiology       Date:  2005-07-07       Impact factor: 1.869

7.  Respiratory disturbance index: an independent predictor of mortality in coronary artery disease.

Authors:  Y Peker; J Hedner; H Kraiczi; S Löth
Journal:  Am J Respir Crit Care Med       Date:  2000-07       Impact factor: 21.405

8.  Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea--hypopnea syndrome.

Authors:  S Imagawa; Y Yamaguchi; M Higuchi; T Neichi; Y Hasegawa; H Y Mukai; N Suzuki; M Yamamoto; T Nagasawa
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

9.  Hematocrit levels in sleep apnea.

Authors:  V Hoffstein; M Herridge; S Mateika; S Redline; K P Strohl
Journal:  Chest       Date:  1994-09       Impact factor: 9.410

10.  Erythropoietin and obstructive sleep apnea.

Authors:  Mikolaj Winnicki; Abu Shamsuzzaman; Paola Lanfranchi; Valentina Accurso; Eric Olson; Diane Davison; Virend K Somers
Journal:  Am J Hypertens       Date:  2004-09       Impact factor: 2.689

View more
  30 in total

Review 1.  Coagulability in obstructive sleep apnea.

Authors:  Christina Liak; M Fitzpatrick
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

2.  Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.

Authors:  Yoshihiko Ikeda; Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Souheil El-Chemaly; Bernadette R Gochuico; Rose M May; Olanda M Hathaway; Shaowei Li; Ji-an Wang; Thomas N Darling; Mario Stylianou; Joel Moss
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-29       Impact factor: 5.464

3.  Development and validation of a questionnaire to identify patients with sleep apnea in Mexican population: Mexican questionnaire to identify sleep apnea.

Authors:  Zaira Romero-López; María Dolores Ochoa-Vázquez; José Antonio Mata-Marín; Luis Gerardo Ochoa-Jiménez; Favio Gerardo Rico-Méndez
Journal:  Sleep Breath       Date:  2010-02-23       Impact factor: 2.816

4.  Complete blood count alterations after six months of continuous positive airway pressure treatment in patients with severe obstructive sleep apnea.

Authors:  Sinem Nedime Sökücü; Cengiz Ozdemir; Levent Dalar; Levent Karasulu; Senay Aydın; Sedat Altın
Journal:  J Clin Sleep Med       Date:  2014-08-15       Impact factor: 4.062

5.  The impact of sleep apnea on postoperative utilization of resources and adverse outcomes.

Authors:  Stavros G Memtsoudis; Ottokar Stundner; Rehana Rasul; Ya-Lin Chiu; Xuming Sun; Satya-Krishna Ramachandran; Roop Kaw; Peter Fleischut; Madhu Mazumdar
Journal:  Anesth Analg       Date:  2014-02       Impact factor: 5.108

6.  Sex-specific associations between erythrocyte measures and obstructive sleep apnea.

Authors:  Taomei Li; Naima Covassin; Lu Tan; Rong Ren; Ye Zhang; Fei Lei; Linghui Yang; Junying Zhou; Hongqiang Sun; Virend K Somers; Xiangdong Tang
Journal:  J Clin Sleep Med       Date:  2020-07-15       Impact factor: 4.062

7.  A dual blocker of endothelin A/B receptors mitigates hypertension but not renal dysfunction in a rat model of chronic kidney disease and sleep apnea.

Authors:  Humberto Morales-Loredo; David Jones; Adelaeda Barrera; Perenkita J Mendiola; Joshua Garcia; Carolyn Pace; Minerva Murphy; Nancy L Kanagy; Laura V Gonzalez Bosc
Journal:  Am J Physiol Renal Physiol       Date:  2019-02-27

8.  NFATc3 is required for intermittent hypoxia-induced hypertension.

Authors:  Sergio de Frutos; Laura Duling; Dominique Alò; Tammy Berry; Olan Jackson-Weaver; Mary Walker; Nancy Kanagy; Laura González Bosc
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-03-21       Impact factor: 4.733

9.  Increased erythropoietin concentration after repeated apneas in humans.

Authors:  Robert de Bruijn; Matt Richardson; Erika Schagatay
Journal:  Eur J Appl Physiol       Date:  2007-12-19       Impact factor: 3.078

10.  Metabolic dysfunction in obstructive sleep apnea: A critical examination of underlying mechanisms.

Authors:  Omar A Mesarwi; Ellora V Sharma; Jonathan C Jun; Vsevolod Y Polotsky
Journal:  Sleep Biol Rhythms       Date:  2015-01       Impact factor: 1.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.